Amryt Pharma PE Ratio 2019-2021 | AMYT
Current and historical p/e ratio for Amryt Pharma (AMYT) from 2019 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Amryt Pharma PE ratio as of October 15, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|Amryt Pharma PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
Amryt Pharma plc is a biopharmaceutical company. It develops and commercializes therapeutics to treat rare diseases. Amryt Pharma plc is based in London, the United Kingdom.